Drug Delivery Devices Market Size, Share & Trends Report

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application, By Route of Administration (Oral, Transdermal, Injectable), By End Use, By Vehicles, By Region, And Segment Forecasts, 2020 - 2027

  • Published Date: Apr, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68038-435-2
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 140

Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Market Segmentation & Scope
                       1.1.1. Route of administration (RoA)
                       1.1.2. Application
                       1.1.3. End-use
                       1.1.4. Vehicles
                       1.1.5. Regional scope
                       1.1.6. Estimates and forecast timeline
                  1.2. Research Methodology
                  1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                           1.3.5.1. Data for primary interviews in North America
                           1.3.5.2. Data for primary interviews in Europe
                           1.3.5.3. Data for primary interviews in Asia Pacific
                           1.3.5.4. Data for primary interviews in Latin America
                           1.3.5.5. Data for Primary interviews in MEA
                  1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                  1.5. Market Formulation & Validation
                  1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                       1.6.2. Volume price analysis (Model 2)
                           1.6.2.1. Approach 2: Volume price analysis
                  1.7. List of Secondary Sources
                  1.8. List of Primary Sources
                  1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                  2.1. Market Outlook
                  2.2. Segment Outlook
                       2.2.1. Route of administration (RoA) outlook
                       2.2.2. Application outlook
                       2.2.3. End-use outlook
                       2.2.4. Vehicle
                       2.2.5. Regional outlook
                  2.3. Competitive Insights
Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope
                  3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                  3.2. Penetration & Growth Prospect Mapping
                  3.3. Industry Value Chain Analysis
                       3.3.1. Reimbursement framework
                  3.4. Market Dynamics
                       3.4.1. Market driver analysis
                           3.4.1.1. Growing demand for novel drug delivery devices
                           3.4.1.2. Increasing prevalence of chronic diseases
                           3.4.1.3. Technological advancement in drug delivery devices
                           3.4.1.4. Growing strategic alliances for drug delivery devices
                       3.4.2. Market restraint analysis
                           3.4.2.1. Challenges associated with various routes of drug delivery devices
                       3.4.3. Industry challenges
                  3.5. Drug Delivery Devices Market Analysis Tools
                       3.5.1. Industry Analysis - Porter’s
                           3.5.1.1. Supplier power
                           3.5.1.2. Buyer power
                           3.5.1.3. Substitution threat
                           3.5.1.4. Threat of new entrant
                           3.5.1.5. Competitive rivalry
                       3.5.2. PESTEL Analysis
                           3.5.2.1. Political landscape
                           3.5.2.2. Technological landscape
                           3.5.2.3. Economic landscape
                       3.5.3. Major Deals & Strategic Alliances Analysis
                       3.5.4. Market Entry Strategies
Chapter 4. Route of Administration (RoA) Estimates & Trend Analysis
                  4.1. Definitions and Scope
                       4.1.1. Oral
                       4.1.2. Inhalation
                       4.1.3. Transdermal
                       4.1.4. Injectable
                       4.1.5. Ocular
                       4.1.6. Nasal
                       4.1.7. Topical
                       4.1.8. Others
                  4.2. RoA Market Share, 2019 & 2027
                  4.3. Segment Dashboard
                  4.4. Global Drug Delivery Devices Market by RoA Outlook
                  4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
                       4.5.1. Oral
                           4.5.1.1. Market estimates and forecast, by oral, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       4.5.2. Inhalation
                           4.5.2.1. Market estimates and forecast, by inhalation, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       4.5.3. Transdermal
                           4.5.3.1. Market estimates and forecast, by transdermal, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       4.5.4. Injectable
                           4.5.4.1. Market estimates and forecast, by injectable, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       4.5.5. Ocular
                           4.5.5.1. Market estimates and forecast, by ocular, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       4.5.6. Nasal
                           4.5.6.1. Market estimates and forecast, by nasal, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       4.5.7. Topical
                           4.5.7.1. Market estimates and forecast, by topical, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       4.5.8. Others
                           4.5.8.1. Market estimates and forecast, by others, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
Chapter 5. Application Estimates & Trend Analysis
                  5.1. Definitions and Scope
                       5.1.1. Oncology
                       5.1.2. Infectious Diseases
                       5.1.3. Respiratory Diseases
                       5.1.4. Diabetes
                       5.1.5. Cardiovascular Diseases
                       5.1.6. Autoimmune Diseases
                       5.1.7. Central Nervous System Disorders
                       5.1.8. Others
                  5.2. Application Market Share, 2019 & 2027
                  5.3. Segment Dashboard
                  5.4. Global Drug Delivery Devices Market by Application Outlook
                  5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
                       5.5.1. Oncology
                           5.5.1.1. Market estimates and forecast, by oncology, 2016 - 2027 (Revenue in USD Billion)
                       5.5.2. Infectious Diseases
                           5.5.2.1. Market estimates and forecast, by infectious diseases, 2016 - 2027 (Revenue in USD Billion)
                       5.5.3. Respiratory Diseases
                           5.5.3.1. Market estimates and forecast, by respiratory diseases, 2016 - 2027 (Revenue in USD Billion)
                       5.5.4. Diabetes
                           5.5.4.1. Market estimates and forecast, by diabetes, 2016 - 2027 (Revenue in USD Billion)
                       5.5.5. Cardiovascular Diseases
                           5.5.5.1. Market estimates and forecast, by cardiovascular diseases, 2016 - 2027 (Revenue in USD Billion)
                       5.5.6. Autoimmune Diseases
                           5.5.6.1. Market estimates and forecast, by autoimmune diseases, 2016 - 2027 (Revenue in USD Billion)
                       5.5.7. Central Nervous System Disorders
                           5.5.7.1. Market estimates and forecast, by central nervous system disorders, 2016 - 2027 (Revenue in USD Billion)
                       5.5.8. Others
                           5.5.8.1. Market estimates and forecast, by others, 2016 - 2027 (Revenue in USD Billion)
Chapter 6. End Use Estimates & Trend Analysis
                  6.1. Definitions and Scope
                       6.1.1. Hospitals
                       6.1.2. Diagnostic Centers
                       6.1.3. Ambulatory Surgery Centers/Clinics
                       6.1.4. Home Care Settings
                       6.1.5. Others
                  6.2. End-Use Market Share, 2019 & 2027
                  6.3. Segment Dashboard
                  6.4. Global Drug Delivery Devices Market by End-Use Outlook
                  6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
                       6.5.1. Hospitals
                           6.5.1.1. Market estimates and forecast, by hospitals, 2016 - 2027 (Revenue in USD Billion)
                       6.5.2. Diagnostic Centers
                           6.5.2.1. Market estimates and forecast, by diagnostic centers, 2016 - 2027 (Revenue in USD Billion)
                       6.5.3. Ambulatory Surgery Centers/Clinics
                           6.5.3.1. Market estimates and forecast, by ambulatory surgery centers, 2016 - 2027 (Revenue in USD Billion)
                       6.5.4. Home Care Settings
                           6.5.4.1. Market estimates and forecast, by home care settings, 2016 - 2027 (Revenue in USD Billion)
                       6.5.5. Others
                           6.5.5.1. Market estimates and forecast, by others, 2016 - 2027 (Revenue in USD Billion)
Chapter 7. Vehicle Estimates & Trend Analysis
                  7.1. Definitions and Scope
                       7.1.1. Hydrogel
                       7.1.2. Micelle
                       7.1.3. Dendrimer
                       7.1.4. Nanoparticle
                       7.1.5. Liposome
                       7.1.6. Scaffold
                       7.1.7. Mesoporous material
                       7.1.8. Niosomes
                  7.2. Vehicle Market Share, 2019 & 2027
                  7.3. Segment Dashboard
                  7.4. Global Drug Delivery Devices Market by Vehicle Outlook
                  7.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
                       7.5.1. Hydrogel
                           7.5.1.1. Market estimates and forecast, by hydrogel, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.1.2. Market estimates and forecast, by application, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       7.5.2. Micelle
                           7.5.2.1. Market estimates and forecast, by micelle, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.2.2. Market estimates and forecast, by application, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       7.5.3. Dendrimer
                           7.5.3.1. Market estimates and forecast, by dendrimer, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.3.2. Market estimates and forecast, by application, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       7.5.4. Nanoparticle
                           7.5.4.1. Market estimates and forecast, by nanoparticle, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.4.2. Market estimates and forecast, by application, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       7.5.5. Liposome
                           7.5.5.1. Market estimates and forecast, by liposome, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.5.2. Market estimates and forecast, by application, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       7.5.6. Scaffold
                           7.5.6.1. Market estimates and forecast, by scaffold, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.6.2. Market estimates and forecast, by application, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       7.5.7. Mesoporous Material
                           7.5.7.1. Market estimates and forecast, by mesoporous material, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.7.2. Market estimates and forecast, by application, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       7.5.8. Niosomes
                           7.5.8.1. Market estimates and forecast, by niosome, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                           7.5.8.2. Market estimates and forecast, by application, 2016 - 2027 (Value & Volume)
Chapter 8. Drug Delivery Devices Market: Regional Estimates & Trend Analysis
                  8.1. Regional market share analysis, 2019 & 2027
                  8.2. Regional Market Dashboard
                  8.3. Global Regional Market Snapshot
                  8.4. Regional Market Share and Leading Players, 2019
                       8.4.1. North America
                       8.4.2. Europe
                       8.4.3. Asia Pacific
                       8.4.4. Latin America
                       8.4.5. Middle East and Africa
                  8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
                       8.5.1. North America
                       8.5.2. Europe
                       8.5.3. Asia Pacific
                       8.5.4. Latin America
                       8.5.5. Middle East and Africa
                  8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027
                  8.7. North America
                       8.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.7.2. The U.S.
                           8.7.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.7.3. Canada
                           8.7.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                  8.8. Europe
                       8.8.1. The U.K.
                           8.8.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.2. Germany
                           8.8.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.3. France
                           8.8.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.4. Italy
                           8.8.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.5. Spain
                           8.8.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.6. Russia
                           8.8.6.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.7. The Netherlands
                           8.8.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.8. Switzerland
                           8.8.8.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.9. Turkey
                           8.8.9.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.8.10. Poland
                           8.8.10.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                  8.9. Asia Pacific
                       8.9.1. Japan
                           8.9.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.2. China
                           8.9.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.3. India
                           8.9.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.4. Thailand
                           8.9.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.5. South Korea
                           8.9.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.6. Indonesia
                           8.9.6.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.7. Taiwan
                           8.9.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.8. Hong Kong
                           8.9.8.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.9. Philippines
                           8.9.9.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.9.10. Malaysia
                           8.9.10.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                  8.10. Latin America
                       8.10.1. Brazil
                           8.10.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.10.2. Mexico
                           8.10.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.10.3. Argentina
                           8.10.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.10.4. Colombia
                           8.10.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.10.5. Chile
                           8.10.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                  8.11. MEA
                       8.11.1. South Africa
                           8.11.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.11.2. Saudi Arabia
                           8.11.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.11.3. UAE
                           8.11.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.11.4. Kuwait
                           8.11.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
                       8.11.5. Qatar
                           8.11.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Billion, Volume, Units)
Chapter 9. Competitive Landscape
                  9.1. Recent Developments & Impact Analysis, By Key Market Participants
                  9.2. Company/Competition Categorization
                       9.2.1. Innovators
                       9.2.2. Market Leaders
                       9.2.3. Emerging Players
                  9.3. Vendor Landscape
                       9.3.1. List of key distributors and channel partners
                       9.3.2. Key customers
                       9.3.3. Key company market share analysis, 2019
                  9.4. Public Companies
                       9.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
                       9.4.2. Company Market Share/Ranking, by region
                       9.4.3. Competitive Dashboard Analysis
                           9.4.3.1. Market Differentiators
                           9.4.3.2. Synergy Analysis: Major Deals and Strategic Alliances
                  9.5. Private Companies
                       9.5.1. List of key emerging companies/technology disruptors/innovators
                       9.5.2. Funding Outlook
                       9.5.3. Regional Network Map
                       9.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
                  9.6. Supplier Ranking
                  9.7. Key company profiled
                       9.7.1. Pfizer, Inc.
                           9.7.1.1. Company overview
                           9.7.1.2. Financial performance
                           9.7.1.3. Product benchmarking
                           9.7.1.4. Strategic initiatives
                       9.7.2. F. Hoffmann-La Roche Ltd.
                           9.7.2.1. Company overview
                           9.7.2.2. Financial performance
                           9.7.2.3. Product benchmarking
                           9.7.2.4. Strategic initiatives
                       9.7.3. Johnson and Johnson Services
                           9.7.3.1. Company overview
                           9.7.3.2. Financial performance
                           9.7.3.3. Product benchmarking
                           9.7.3.4. Strategic initiatives
                       9.7.4. Novartis AG
                           9.7.4.1. Company overview
                           9.7.4.2. Financial performance
                           9.7.4.3. Product benchmarking
                           9.7.4.4. Strategic initiatives
                       9.7.5. Bayer AG
                           9.7.5.1. Company overview
                           9.7.5.2. Financial performance
                           9.7.5.3. Product benchmarking
                           9.7.5.4. Strategic initiatives
                       9.7.6. BD
                           9.7.6.1. Company overview
                           9.7.6.2. Financial performance
                           9.7.6.3. Product benchmarking
                           9.7.6.4. Strategic initiatives
                       9.7.7. Uniqure N.V.
                           9.7.7.1. Company overview
                           9.7.7.2. Financial performance
                           9.7.7.3. Product benchmarking
                           9.7.7.4. Strategic initiatives
                       9.7.8. SiBiono GeneTech Co.
                           9.7.8.1. Company overview
                           9.7.8.2. Financial performance
                           9.7.8.3. Product benchmarking
                           9.7.8.4. Strategic initiatives
                       9.7.9. Shanghai Sunway Biotech Co., Ltd
                           9.7.9.1. Company overview
                           9.7.9.2. Financial performance
                           9.7.9.3. Product benchmarking
                           9.7.9.4. Strategic initiatives
                       9.7.10. Human Stem Cells Institute
                           9.7.10.1. Company overview
                           9.7.10.2. Financial performance
                           9.7.10.3. Product benchmarking
                           9.7.10.4. Strategic initiatives 


List of Tables

Table 1 List of Abbreviation
Table 2 North America drug delivery devices market, by region, 2016 - 2027 (USD Billion)
Table 3 North America drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 4 North America drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 5 North America drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 6 North America drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 7 North America drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 8 North America drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 9 North America hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 10 North America micelle market, by application, 2016 - 2027 (USD Billion)
Table 11 North America dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 12 North America nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 13 North America liposome market, by application, 2016 - 2027 (USD Billion)
Table 14 North America scaffold market, by application, 2016 - 2027 (USD Billion)
Table 15 North America mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 16 North America niosomes market, by application, 2016 - 2027 (USD Billion)
Table 17 U.S. drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 18 U.S. drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 19 U.S. drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 20 U.S. drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 21 U.S. hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 22 U.S. micelle market, by application, 2016 - 2027 (USD Billion)
Table 23 U.S. dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 24 U.S. nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 25 U.S. liposome market, by application, 2016 - 2027 (USD Billion)
Table 26 U.S. scaffold market, by application, 2016 - 2027 (USD Billion)
Table 27 U.S. mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 28 U.S. niosomes market, by application, 2016 - 2027 (USD Billion)
Table 29 Canada drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 30 Canada drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 31 Canada drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 32 Canada drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 33 Canada hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 34 Canada micelle market, by application, 2016 - 2027 (USD Billion)
Table 35 Canada dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 36 Canada nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 37 Canada liposome market, by application, 2016 - 2027 (USD Billion)
Table 38 Canada scaffold market, by application, 2016 - 2027 (USD Billion)
Table 39 Canada mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 40 Canada niosomes market, by application, 2016 - 2027 (USD Billion)
Table 41 Europe drug delivery devices market, by region, 2016 - 2027 (USD Billion)
Table 42 Europe drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 43 Europe drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 44 Europe drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 45 Europe drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 46 Europe hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 47 Europe micelle market, by application, 2016 - 2027 (USD Billion)
Table 48 Europe dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 49 Europe nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 50 Europe liposome market, by application, 2016 - 2027 (USD Billion)
Table 51 Europe scaffold market, by application, 2016 - 2027 (USD Billion)
Table 52 Europe mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 53 Europe niosomes market, by application, 2016 - 2027 (USD Billion)
Table 54 Germany drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 55 Germany drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 56 Germany drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 57 Germany drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 58 Germany hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 59 Germany micelle market, by application, 2016 - 2027 (USD Billion)
Table 60 Germany dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 61 Germany nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 62 Germany liposome market, by application, 2016 - 2027 (USD Billion)
Table 63 Germany scaffold market, by application, 2016 - 2027 (USD Billion)
Table 64 Germany mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 65 Germany niosomes market, by application, 2016 - 2027 (USD Billion)
Table 66 U.K. drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 67 U.K. drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 68 U.K. drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 69 U.K. drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 70 U.K. hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 71 U.K. micelle market, by application, 2016 - 2027 (USD Billion)
Table 72 U.K. dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 73 U.K. nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 74 U.K. liposome market, by application, 2016 - 2027 (USD Billion)
Table 75 U.K. scaffold market, by application, 2016 - 2027 (USD Billion)
Table 76 U.K. mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 77 U.K. niosomes market, by application, 2016 - 2027 (USD Billion)
Table 78 France drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 79 France drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 80 France drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 81 France drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 82 France hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 83 France micelle market, by application, 2016 - 2027 (USD Billion)
Table 84 France dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 85 France nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 86 France liposome market, by application, 2016 - 2027 (USD Billion)
Table 87 France scaffold market, by application, 2016 - 2027 (USD Billion)
Table 88 France mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 89 France niosomes market, by application, 2016 - 2027 (USD Billion)
Table 90 Italy drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 91 Italy drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 92 Italy drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 93 Italy drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 94 Italy hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 95 Italy micelle market, by application, 2016 - 2027 (USD Billion)
Table 96 Italy dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 97 Italy nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 98 Italy liposome market, by application, 2016 - 2027 (USD Billion)
Table 99 Italy scaffold market, by application, 2016 - 2027 (USD Billion)
Table 100 Italy mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 101 Italy niosomes market, by application, 2016 - 2027 (USD Billion)
Table 102 Spain drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 103 Spain drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 104 Spain drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 105 Spain drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 106 Spain hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 107 Spain micelle market, by application, 2016 - 2027 (USD Billion)
Table 108 Spain dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 109 Spain nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 110 Spain liposome market, by application, 2016 - 2027 (USD Billion)
Table 111 Spain scaffold market, by application, 2016 - 2027 (USD Billion)
Table 112 Spain mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 113 Spain niosomes market, by application, 2016 - 2027 (USD Billion)
Table 114 Russia drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 115 Russia drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 116 Russia drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 117 Russia drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 118 Russia hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 119 Russia micelle market, by application, 2016 - 2027 (USD Billion)
Table 120 Russia dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 121 Russia nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 122 Russia liposome market, by application, 2016 - 2027 (USD Billion)
Table 123 Russia scaffold market, by application, 2016 - 2027 (USD Billion)
Table 124 Russia mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 125 Russia niosomes market, by application, 2016 - 2027 (USD Billion)
Table 126 The Netherlands drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 127 The Netherlands drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 128 The Netherlands drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 129 The Netherlands drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 130 The Netherlands hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 131 The Netherlands micelle market, by application, 2016 - 2027 (USD Billion)
Table 132 The Netherlands dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 133 The Netherlands nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 134 The Netherlands liposome market, by application, 2016 - 2027 (USD Billion)
Table 135 The Netherlands scaffold market, by application, 2016 - 2027 (USD Billion)
Table 136 The Netherlands mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 137 The Netherlands niosomes market, by application, 2016 - 2027 (USD Billion)
Table 138 Switzerland drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 139 Switzerland drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 140 Switzerland drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 141 Switzerland drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 142 Switzerland hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 143 Switzerland micelle market, by application, 2016 - 2027 (USD Billion)
Table 144 Switzerland dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 145 Switzerland nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 146 Switzerland liposome market, by application, 2016 - 2027 (USD Billion)
Table 147 Switzerland scaffold market, by application, 2016 - 2027 (USD Billion)
Table 148 Switzerland mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 149 Switzerland niosomes market, by application, 2016 - 2027 (USD Billion)
Table 150 Turkey drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 151 Turkey drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 152 Turkey drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 153 Turkey drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 154 Turkey hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 155 Turkey micelle market, by application, 2016 - 2027 (USD Billion)
Table 156 Turkey dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 157 Turkey nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 158 Turkey liposome market, by application, 2016 - 2027 (USD Billion)
Table 159 Turkey scaffold market, by application, 2016 - 2027 (USD Billion)
Table 160 Turkey mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 161 Turkey niosomes market, by application, 2016 - 2027 (USD Billion)
Table 162 Poland drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 163 Poland drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 164 Poland drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 165 Poland drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 166 Poland hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 167 Poland micelle market, by application, 2016 - 2027 (USD Billion)
Table 168 Poland dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 169 Poland nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 170 Poland liposome market, by application, 2016 - 2027 (USD Billion)
Table 171 Poland scaffold market, by application, 2016 - 2027 (USD Billion)
Table 172 Poland mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 173 Poland niosomes market, by application, 2016 - 2027 (USD Billion)
Table 174 APAC drug delivery devices market, by region, 2016 - 2027 (USD Billion)
Table 175 APAC drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 176 APAC drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 177 APAC drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 178 APAC drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 179 APAC hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 180 APAC micelle market, by application, 2016 - 2027 (USD Billion)
Table 181 APAC dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 182 APAC nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 183 APAC liposome market, by application, 2016 - 2027 (USD Billion)
Table 184 APAC scaffold market, by application, 2016 - 2027 (USD Billion)
Table 185 APAC mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 186 APAC niosomes market, by application, 2016 - 2027 (USD Billion)
Table 187 China drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 188 China drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 189 China drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 190 China drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 191 China hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 192 China micelle market, by application, 2016 - 2027 (USD Billion)
Table 193 China dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 194 China nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 195 China liposome market, by application, 2016 - 2027 (USD Billion)
Table 196 China scaffold market, by application, 2016 - 2027 (USD Billion)
Table 197 China mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 198 China niosomes market, by application, 2016 - 2027 (USD Billion)
Table 199 Japan drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 200 Japan drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 201 Japan drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 202 Japan drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 203 Japan hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 204 Japan micelle market, by application, 2016 - 2027 (USD Billion)
Table 205 Japan dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 206 Japan nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 207 Japan liposome market, by application, 2016 - 2027 (USD Billion)
Table 208 Japan scaffold market, by application, 2016 - 2027 (USD Billion)
Table 209 Japan mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 210 Japan niosomes market, by application, 2016 - 2027 (USD Billion)
Table 211 India drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 212 India drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 213 India drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 214 India drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 215 India hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 216 India micelle market, by application, 2016 - 2027 (USD Billion)
Table 217 India dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 218 India nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 219 India liposome market, by application, 2016 - 2027 (USD Billion)
Table 220 India scaffold market, by application, 2016 - 2027 (USD Billion)
Table 221 India mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 222 India niosomes market, by application, 2016 - 2027 (USD Billion)
Table 223 Thailand drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 224 Thailand drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 225 Thailand drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 226 Thailand drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 227 Thailand hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 228 Thailand micelle market, by application, 2016 - 2027 (USD Billion)
Table 229 Thailand dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 230 Thailand nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 231 Thailand liposome market, by application, 2016 - 2027 (USD Billion)
Table 232 Thailand scaffold market, by application, 2016 - 2027 (USD Billion)
Table 233 Thailand mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 234 Thailand niosomes market, by application, 2016 - 2027 (USD Billion)
Table 235 South Korea drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 236 South Korea drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 237 South Korea drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 238 South Korea drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 239 South Korea hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 240 South Korea micelle market, by application, 2016 - 2027 (USD Billion)
Table 241 South Korea dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 242 South Korea nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 243 South Korea liposome market, by application, 2016 - 2027 (USD Billion)
Table 244 South Korea scaffold market, by application, 2016 - 2027 (USD Billion)
Table 245 South Korea mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 246 South Korea niosomes market, by application, 2016 - 2027 (USD Billion)
Table 247 Indonesia drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 248 Indonesia drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 249 Indonesia drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 250 Indonesia drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 251 Indonesia hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 252 Indonesia micelle market, by application, 2016 - 2027 (USD Billion)
Table 253 Indonesia dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 254 Indonesia nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 255 Indonesia liposome market, by application, 2016 - 2027 (USD Billion)
Table 256 Indonesia scaffold market, by application, 2016 - 2027 (USD Billion)
Table 257 Indonesia mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 258 Indonesia niosomes market, by application, 2016 - 2027 (USD Billion)
Table 259 Taiwan drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 260 Taiwan drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 261 Taiwan drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 262 Taiwan drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 263 Taiwan hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 264 Taiwan micelle market, by application, 2016 - 2027 (USD Billion)
Table 265 Taiwan dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 266 Taiwan nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 267 Taiwan liposome market, by application, 2016 - 2027 (USD Billion)
Table 268 Taiwan scaffold market, by application, 2016 - 2027 (USD Billion)
Table 269 Taiwan mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 270 Taiwan niosomes market, by application, 2016 - 2027 (USD Billion)
Table 271 Hong Kong drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 272 Hong Kong drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 273 Hong Kong drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 274 Hong Kong drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 275 Hong Kong hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 276 Hong Kong micelle market, by application, 2016 - 2027 (USD Billion)
Table 277 Hong Kong dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 278 Hong Kong nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 279 Hong Kong liposome market, by application, 2016 - 2027 (USD Billion)
Table 280 Hong Kong scaffold market, by application, 2016 - 2027 (USD Billion)
Table 281 Hong Kong mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 282 Hong Kong niosomes market, by application, 2016 - 2027 (USD Billion)
Table 283 Philippines drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 284 Philippines drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 285 Philippines drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 286 Philippines drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 287 Philippines hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 288 Philippines micelle market, by application, 2016 - 2027 (USD Billion)
Table 289 Philippines dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 290 Philippines nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 291 Philippines liposome market, by application, 2016 - 2027 (USD Billion)
Table 292 Philippines scaffold market, by application, 2016 - 2027 (USD Billion)
Table 293 Philippines mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 294 Philippines niosomes market, by application, 2016 - 2027 (USD Billion)
Table 295 Malaysia drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 296 Malaysia drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 297 Malaysia drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 298 Malaysia drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 299 Malaysia hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 300 Malaysia micelle market, by application, 2016 - 2027 (USD Billion)
Table 301 Malaysia dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 302 Malaysia nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 303 Malaysia liposome market, by application, 2016 - 2027 (USD Billion)
Table 304 Malaysia scaffold market, by application, 2016 - 2027 (USD Billion)
Table 305 Malaysia mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 306 Malaysia niosomes market, by application, 2016 - 2027 (USD Billion)
Table 307 Latin America drug delivery devices market, by region, 2016 - 2027 (USD Billion)
Table 308 Latin America drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 309 Latin America drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 310 Latin America drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 311 Latin America drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 312 Latin America hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 313 Latin America micelle market, by application, 2016 - 2027 (USD Billion)
Table 314 Latin America dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 315 Latin America nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 316 Latin America liposome market, by application, 2016 - 2027 (USD Billion)
Table 317 Latin America scaffold market, by application, 2016 - 2027 (USD Billion)
Table 318 Latin America mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 319 Latin America niosomes market, by application, 2016 - 2027 (USD Billion)
Table 320 Brazil drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 321 Brazil drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 322 Brazil drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 323 Brazil drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 324 Brazil hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 325 Brazil micelle market, by application, 2016 - 2027 (USD Billion)
Table 326 Brazil dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 327 Brazil nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 328 Brazil liposome market, by application, 2016 - 2027 (USD Billion)
Table 329 Brazil scaffold market, by application, 2016 - 2027 (USD Billion)
Table 330 Brazil mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 331 Brazil niosomes market, by application, 2016 - 2027 (USD Billion)
Table 332 Mexico drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 333 Mexico drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 334 Mexico drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 335 Mexico drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 336 Mexico hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 337 Mexico micelle market, by application, 2016 - 2027 (USD Billion)
Table 338 Mexico dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 339 Mexico nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 340 Mexico liposome market, by application, 2016 - 2027 (USD Billion)
Table 341 Mexico scaffold market, by application, 2016 - 2027 (USD Billion)
Table 342 Mexico mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 343 Mexico niosomes market, by application, 2016 - 2027 (USD Billion)
Table 344 Argentina drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 345 Argentina drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 346 Argentina drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 347 Argentina drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 348 Argentina hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 349 Argentina micelle market, by application, 2016 - 2027 (USD Billion)
Table 350 Argentina dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 351 Argentina nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 352 Argentina liposome market, by application, 2016 - 2027 (USD Billion)
Table 353 Argentina scaffold market, by application, 2016 - 2027 (USD Billion)
Table 354 Argentina mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 355 Argentina niosomes market, by application, 2016 - 2027 (USD Billion)
Table 356 Colombia drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 357 Colombia drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 358 Colombia drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 359 Colombia drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 360 Colombia hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 361 Colombia micelle market, by application, 2016 - 2027 (USD Billion)
Table 362 Colombia dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 363 Colombia nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 364 Colombia liposome market, by application, 2016 - 2027 (USD Billion)
Table 365 Colombia scaffold market, by application, 2016 - 2027 (USD Billion)
Table 366 Colombia mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 367 Colombia niosomes market, by application, 2016 - 2027 (USD Billion)
Table 368 Chile drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 369 Chile drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 370 Chile drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 371 Chile drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 372 Chile hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 373 Chile micelle market, by application, 2016 - 2027 (USD Billion)
Table 374 Chile dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 375 Chile nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 376 Chile liposome market, by application, 2016 - 2027 (USD Billion)
Table 377 Chile scaffold market, by application, 2016 - 2027 (USD Billion)
Table 378 Chile mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 379 Chile niosomes market, by application, 2016 - 2027 (USD Billion)
Table 380 Middle East and Africa drug delivery devices market, by region, 2016 - 2027 (USD Billion)
Table 381 Middle East and Africa drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 382 Middle East and Africa drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 383 Middle East and Africa drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 384 Middle East and Africa drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 385 Middle East and Africa hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 386 Middle East and Africa micelle market, by application, 2016 - 2027 (USD Billion)
Table 387 Middle East and Africa dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 388 Middle East and Africa nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 389 Middle East and Africa liposome market, by application, 2016 - 2027 (USD Billion)
Table 390 Middle East and Africa scaffold market, by application, 2016 - 2027 (USD Billion)
Table 391 Middle East and Africa mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 392 Middle East and Africa niosomes market, by application, 2016 - 2027 (USD Billion)
Table 393 South Africa drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 394 South Africa drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 395 South Africa drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 396 South Africa drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 397 South Africa hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 398 South Africa micelle market, by application, 2016 - 2027 (USD Billion)
Table 399 South Africa dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 400 South Africa nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 401 South Africa liposome market, by application, 2016 - 2027 (USD Billion)
Table 402 South Africa scaffold market, by application, 2016 - 2027 (USD Billion)
Table 403 South Africa mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 404 South Africa niosomes market, by application, 2016 - 2027 (USD Billion)
Table 405 Saudi Arabia drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 406 Saudi Arabia drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 407 Saudi Arabia drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 408 Saudi Arabia drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 409 Saudi Arabia hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 410 Saudi Arabia micelle market, by application, 2016 - 2027 (USD Billion)
Table 411 Saudi Arabia dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 412 Saudi Arabia nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 413 Saudi Arabia liposome market, by application, 2016 - 2027 (USD Billion)
Table 414 Saudi Arabia scaffold market, by application, 2016 - 2027 (USD Billion)
Table 415 Saudi Arabia mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 416 Saudi Arabia niosomes market, by application, 2016 - 2027 (USD Billion)
Table 417 UAE drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 418 UAE drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 419 UAE drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 420 UAE drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 421 UAE hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 422 UAE micelle market, by application, 2016 - 2027 (USD Billion)
Table 423 UAE dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 424 UAE nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 425 UAE liposome market, by application, 2016 - 2027 (USD Billion)
Table 426 UAE scaffold market, by application, 2016 - 2027 (USD Billion)
Table 427 UAE mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 428 UAE niosomes market, by application, 2016 - 2027 (USD Billion)
Table 429 Kuwait drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 430 Kuwait drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 431 Kuwait drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 432 Kuwait drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 433 Kuwait hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 434 Kuwait micelle market, by application, 2016 - 2027 (USD Billion)
Table 435 Kuwait dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 436 Kuwait nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 437 Kuwait liposome market, by application, 2016 - 2027 (USD Billion)
Table 438 Kuwait scaffold market, by application, 2016 - 2027 (USD Billion)
Table 439 Kuwait mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 440 Kuwait niosomes market, by application, 2016 - 2027 (USD Billion)
Table 441 Qatar drug delivery devices market, by RoA, 2016 - 2027 (USD Billion)
Table 442 Qatar drug delivery devices market, by application, 2016 - 2027 (USD Billion)
Table 443 Qatar drug delivery devices market, by end-use, 2016 - 2027 (USD Billion)
Table 444 Qatar drug delivery devices market, by vehicle, 2016 - 2027 (USD Billion)
Table 445 Qatar hydrogel market, by application, 2016 - 2027 (USD Billion)
Table 446 Qatar micelle market, by application, 2016 - 2027 (USD Billion)
Table 447 Qatar dendrimer market, by application, 2016 - 2027 (USD Billion)
Table 448 Qatar nanoparticle market, by application, 2016 - 2027 (USD Billion)
Table 449 Qatar liposome market, by application, 2016 - 2027 (USD Billion)
Table 450 Qatar scaffold market, by application, 2016 - 2027 (USD Billion)
Table 451 Qatar mesoporous material market, by application, 2016 - 2027 (USD Billion)
Table 452 Qatar niosomes market, by application, 2016 - 2027 (USD Billion)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Drug delivery devices: market outlook
Fig. 14 Drug delivery devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Drug delivery devices market driver impact
Fig. 20 Drug delivery devices market restraint impact
Fig. 21 Drug delivery devices market strategic initiatives analysis
Fig. 22 Drug delivery devices market: RoA movement analysis
Fig. 23 Drug delivery devices market: RoA outlook and key takeaways
Fig. 24 Oral market estimates and forecast, 2016 - 2027
Fig. 25 Inhalation market estimates and forecast, 2016 - 2027
Fig. 26 Transdermal market estimates and forecast, 2016 - 2027
Fig. 27 Injectable market estimates and forecast, 2016 - 2027
Fig. 28 Ocular market estimates and forecast, 2016 - 2027
Fig. 29 Nasal market estimates and forecast, 2016 - 2027
Fig. 30 Topical market estimates and forecast, 2016 - 2027
Fig. 31 Others market estimates and forecast, 2016 - 2027
Fig. 32 Drug delivery devices market: application movement analysis
Fig. 33 Drug delivery devices market: application outlook and key takeaways
Fig. 34 Oncology market estimates and forecast, 2016 - 2027
Fig. 35 Infectious diseases estimates and forecast, 2016 - 2027
Fig. 36 Respiratory diseases estimates and forecast, 2016 - 2027
Fig. 37 Diabetes estimates and forecast, 2016 - 2027
Fig. 38 Cardiovascular diseases estimates and forecast, 2016 - 2027
Fig. 39 Autoimmune diseases estimates and forecast, 2016 - 2027
Fig. 40 Central nervous system disorders estimates and forecast, 2016 - 2027
Fig. 41 Others estimates and forecast, 2016 - 2027
Fig. 42 Drug delivery devices market: end-use movement analysis
Fig. 43 Drug delivery devices market: end-use outlook and key takeaways
Fig. 44 Hospitals estimates and forecast, 2016 - 2027
Fig. 45 Diagnostic centers estimates and forecast, 2016 - 2027
Fig. 46 Ambulatory surgery centers/clinics estimates and forecast, 2016 - 2027
Fig. 47 Home care setting estimates and forecast, 2016 - 2027
Fig. 48 Others estimates and forecast, 2016 - 2027
Fig. 49 Drug delivery devices market: vehicle movement analysis
Fig. 50 Drug delivery devices market: vehicle outlook and key takeaways
Fig. 51 Hydrogel estimates and forecast, 2016 - 2027
Fig. 52 Micelle centers estimates and forecast, 2016 - 2027
Fig. 53 Dendrimer estimates and forecast, 2016 - 2027
Fig. 54 Nanoparticle estimates and forecast, 2016 - 2027
Fig. 55 Liposome estimates and forecast, 2016 - 2027
Fig. 56 Scaffold estimates and forecast, 2016 - 2027
Fig. 57 Mesoporous material estimates and forecast, 2016 - 2027
Fig. 58 Niosome estimates and forecast, 2016 - 2027
Fig. 59 Global drug delivery devices market: regional movement analysis
Fig. 60 Global drug delivery market: regional outlook and key takeaways
Fig. 61 Global market share and leading players
Fig. 62 North America market share and leading players
Fig. 63 Europe market share and leading players
Fig. 64 Asia Pacific market share and leading players
Fig. 65 Latin America market share and leading players
Fig. 66 Middle East & Africa market share and leading players
Fig. 67 North America: SWOT
Fig. 68 Europe SWOT
Fig. 69 Asia Pacific SWOT
Fig. 70 Latin America SWOT
Fig. 71 MEA SWOT
Fig. 72 North America, by country
Fig. 73 North America
Fig. 74 North America market estimates and forecast, 2016 - 2027
Fig. 75 The U.S.
Fig. 76 U.S. market estimates and forecast, 2016 - 2027
Fig. 77 Canada
Fig. 78 Canada market estimates and forecast, 2016 - 2027
Fig. 79 Europe
Fig. 80 Europe. market estimates and forecast, 2016 - 2027
Fig. 81 The U.K.
Fig. 82 U.K. market estimates and forecast, 2016 - 2027
Fig. 83 Germany
Fig. 84 Germany market estimates and forecast, 2016 - 2027
Fig. 85 France
Fig. 86 France market estimates and forecast, 2016 - 2027
Fig. 87 Italy
Fig. 88 Italy market estimates and forecast, 2016 - 2027
Fig. 89 Spain
Fig. 90 Spain market estimates and forecast, 2016 - 2027
Fig. 91 Russia
Fig. 92 Russia market estimates and forecast, 2016 - 2027
Fig. 93 The Netherlands
Fig. 94 The Netherlands market estimates and forecast, 2016 - 2027
Fig. 95 Switzerland
Fig. 96 Switzerland market estimates and forecast, 2016 - 2027
Fig. 97 Turkey
Fig. 98 Turkey market estimates and forecast, 2016 - 2027
Fig. 99 Poland
Fig. 100 Poland market estimates and forecast, 2016 - 2027
Fig. 101 Asia Pacific
Fig. 102 Asia Pacific market estimates and forecast, 2016 - 2027
Fig. 103 China
Fig. 104 China market estimates and forecast, 2016 - 2027
Fig. 105 Japan
Fig. 106 Japan market estimates and forecast, 2016 - 2027
Fig. 107 India
Fig. 108 India market estimates and forecast, 2016 - 2027
Fig. 109 Thailand
Fig. 110 Thailand. market estimates and forecast, 2016 - 2027
Fig. 111 South Korea
Fig. 112 South Korea market estimates and forecast, 2016 - 2027
Fig. 113 Indonesia
Fig. 114 Indonesia market estimates and forecast, 2016 - 2027
Fig. 115 Taiwan
Fig. 116 Taiwan market estimates and forecast, 2016 - 2027
Fig. 117 Hong Kong
Fig. 118 Hong Kong market estimates and forecast, 2016 - 2027
Fig. 119 Philippines
Fig. 120 Philippines market estimates and forecast, 2016 - 2027
Fig. 121 Malaysia
Fig. 122 Malaysia market estimates and forecast, 2016 - 2027
Fig. 123 Latin America
Fig. 124 Latin America market estimates and forecast, 2016 - 2027
Fig. 125 Brazil
Fig. 126 Brazil market estimates and forecast, 2016 - 2027
Fig. 127 Mexico
Fig. 128 Mexico market estimates and forecast, 2016 - 2027
Fig. 129 Argentina
Fig. 130 Argentina market estimates and forecast, 2016 - 2027
Fig. 131 Colombia
Fig. 132 Colombia market estimates and forecast, 2016 - 2027
Fig. 133 Chile
Fig. 134 Chile market estimates and forecast, 2016 - 2027
Fig. 135 Middle East and Africa
Fig. 136 Middle East and Africa. market estimates and forecast, 2016 - 2027
Fig. 137 South Africa
Fig. 138 South Africa market estimates and forecast, 2016 - 2027
Fig. 139 Saudi Arabia
Fig. 140 Saudi Arabia market estimates and forecast, 2016 - 2027
Fig. 141 UAE
Fig. 142 UAE market estimates and forecast, 2016 - 2027
Fig. 143 Kuwait
Fig. 144 Kuwait market estimates and forecast, 2016 - 2027
Fig. 145 Qatar
Fig. 146 Qatar market estimates and forecast, 2016 - 2027
Fig. 147 Participant categorization- drug delivery devices market
Fig. 148 Market share of key market players- drug delivery devices market

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.